NPT
DAWN

National Philanthropic Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

National Philanthropic Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150,000
Closed -$1.06M – 394
2025
Q3 		$1.06M Hold
150,000
– – 0.01% 185
2025
Q2 		$975K Buy
+150,000
New +$1.03M 0.01% 178

Other funds holding DAWN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

National Philanthropic Trust's DAWN Position: Q4 2025 in Review

National Philanthropic Trust sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 150,000 shares — an estimated $1.06M sold.

National Philanthropic Trust first reported a position in DAWN in Q2 2025 and held it in 2 quarters. The position peaked at $1.06M in Q3 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

  • National Philanthropic Trust reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • National Philanthropic Trust sold 150,000 Day One Biopharmaceuticals shares in Q4 2025, an estimated $1.06M.
  • National Philanthropic Trust first reported a position in Day One Biopharmaceuticals in Q2 2025 and held it in 2 quarters.
  • National Philanthropic Trust's Day One Biopharmaceuticals position peaked at $1.06M in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on National Philanthropic Trust's 13F filing for Q4 2025, filed 15 May 2026.